A neural network developed at the Technion – Israel Institute of Technology managed to correctly determine whether a breast cancer tumor expresses a protein that can be used for immunotherapy purposes – and where artificial intelligence disagreed with a human pathologist’s conclusion, a second test proved AI to be correct.

And while personalized immunotherapy treatment is on the rise, the number of pathologists, or doctors who specialize in examining tissue to determine the specific diagnosis needed for personalized medicine, is on the decline.

Image - courtesy of the Technion – Israel Institute of Technology